DSY Dassault Systemes SA

Dassault Systèmes: disclosure of trading in own shares

Dassault Systèmes: disclosure of trading in own shares

Vélizy-Villacoublay, October 1, 2021

DISCLOSURE OF TRADING IN OWN SHARES

(Repurchase program decided by the General Meeting of Shareholders of May 26, 2021)

Issuer: Dassault Systèmes SE

Type of securities: ordinary shares

Period: September 24 to September 29, 2021

Detailed information (presentation by day and by market and transaction-by-transaction details) can be consulted on the website of Dassault Systèmes:

Presentation of the trading in own shares by day and by market

Name of issuerIdentification code of the issuerDate of tradingIdentification code of the financial instrumentDaily total volume (in number of shares)Daily weighted average acquisition price of the shares*Market
DASSAULT SYSTEMES96950065LBWY0APQIM8624-Sep-21FR0014003TT844 92749,4998XPAR
DASSAULT SYSTEMES96950065LBWY0APQIM8624-Sep-21FR0014003TT815 89049,4999DXE
DASSAULT SYSTEMES96950065LBWY0APQIM8624-Sep-21FR0014003TT85 32449,4952TQE
DASSAULT SYSTEMES96950065LBWY0APQIM8627-Sep-21FR0014003TT8298 27848,5524XPAR
DASSAULT SYSTEMES96950065LBWY0APQIM8627-Sep-21FR0014003TT894 26048,8411DXE
DASSAULT SYSTEMES96950065LBWY0APQIM8627-Sep-21FR0014003TT824 77548,8099TQE
DASSAULT SYSTEMES96950065LBWY0APQIM8628-Sep-21FR0014003TT8316 39445,9835XPAR
DASSAULT SYSTEMES96950065LBWY0APQIM8628-Sep-21FR0014003TT8102 46945,9667DXE
DASSAULT SYSTEMES96950065LBWY0APQIM8628-Sep-21FR0014003TT826 66545,9120TQE
DASSAULT SYSTEMES96950065LBWY0APQIM8629-Sep-21FR0014003TT8331 34646,0318XPAR
DASSAULT SYSTEMES96950065LBWY0APQIM8629-Sep-21FR0014003TT8110 47746,0241DXE
DASSAULT SYSTEMES96950065LBWY0APQIM8629-Sep-21FR0014003TT829 47546,0361TQE

(*)The weighted average unit price is a rounded price

CONTACTS:

Dassault Systèmes:

Investor Relations

François-José Bordonado/Béatrix Martinez

24



Attachment



EN
01/10/2021

Underlying

DSYDassault Systemes SA

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Dassault Systemes SA

Free Trial
DSY Dassault System...

Dassault Systemes Sa: 1 director

A director at Dassault Systemes Sa bought 15,000 shares at 23.986EUR and the significance rating of the trade was 58/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years ...

DSY DASSAULT SYSTEMES SA
3h / 56m 3h / 56m 1 EN
 PRESS RELEASE
Free
DSY Dassault System...

Update: Dassault Systèmes: Medidata Extends Collaboration with Sanofi ...

Update: Dassault Systèmes: Medidata Extends Collaboration with Sanofi for the Development of New Therapies with an Improved Patient Journey Medidata Extends Collaboration with Sanofi for the Development of New Therapies with an Improved Patient Journey  Expanded 10-plus-year collaboration will leverage Medidata Experiences with the goal of streamlining clinical processes and data, enhancing patient care New York – Oct. 23, 2025 –, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced an extension of their collaboration w...

October 28, 2025 1 EN
 PRESS RELEASE
Free
DSY Dassault System...

Mise à jour : Dassault Systèmes : Medidata étend sa collaboration avec...

Mise à jour : Dassault Systèmes : Medidata étend sa collaboration avec Sanofi pour développer de nouvelles thérapies visant à améliorer le parcours patient Medidata étend sa collaboration avec Sanofi pour développer de nouvelles thérapies visant à améliorer le parcours patient Une collaboration de plus de dix ans renforcée autour des Medidata Experiences, a pour l’objectif d’optimiser les processus et les données cliniques en améliorant la prise en charge des patients. New York, le 23 octobre 2025 – , marque de Dassault Systèmes et leader des solutions numériques pour les essais cliniques...

October 28, 2025 1 EN
 PRESS RELEASE
Free
DSY Dassault System...

Mise à jour : Dassault Systèmes : Sanofi renforce sa collaboration ave...

Mise à jour : Dassault Systèmes : Sanofi renforce sa collaboration avec Medidata pour accélérer le développement de nouvelles thérapies et améliorer le parcours patient Sanofi renforce sa collaboration avec Medidata pour accélérer le développement de nouvelles thérapies et améliorer le parcours patient Une collaboration de plus de dix ans élargie autour des Medidata Experiences, permettant à Sanofi d’optimiser ses opérations, d’affiner la qualité de ses données et d’améliorer la prise en charge des patients. New York, le 23 octobre 2025 – , marque de Dassault Systèmes et leader des soluti...

October 28, 2025 1 EN
 PRESS RELEASE
Free
DSY Dassault System...

Update: Dassault Systèmes: Medidata Extends Collaboration with Sanofi ...

Update: Dassault Systèmes: Medidata Extends Collaboration with Sanofi for the Development of New Therapies with an Improved Patient Journey Medidata Extends Collaboration with Sanofi for the Development of New Therapies with an Improved Patient Journey  Expanded 10-plus-year collaboration will leverage Medidata Experiences with the goal of streamlining clinical processes and data, enhancing patient care New York – Oct. 23, 2025 –, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced an extension of their collaboration w...

October 28, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch